Melody

About Namida Lab

Namida Lab is a revenue-stage diagnostics company pioneering the use of tears as a biofluid for early cancer detection. Its core technology platform analyzes the proteomic and genomic content of tears to identify biomarkers associated with cancers, starting with breast cancer. The company has commercialized two initial products: Auria, an at-home breast cancer screening test, and Melody, a clinical diagnostic for providers. By focusing on a non-invasive, easily collectible fluid, Namida Lab aims to disrupt traditional screening paradigms and improve patient compliance and outcomes.

Therapeutic Areas